Thus, the findings of the present study suggest that MSCs, MSC-derived exosome and miR-26a-5p are potential therapeutics, and MALAT1 is a promising target for the treatment of ALI in sepsis, which provides a new avenue and new insights for rescuing the syndrome. This evidence concerns the gene MALAT1 and Sepsis.